Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group. 1983

S Haahr, and A Møller-Larsen, and E Pedersen

A group of multiple sclerosis (MS) patients (n = 50), most of them in a stable or slightly progressive phase was studied together with a group of neurological control (NC) patients with CNS lesions (n = 38) comparable in age and disability and an age matched group of healthy persons (n = 46). On stimulation of lymphocytes with herpes simplex virus (HSV), cytomegalovirus (CMV) and varicella zoster virus (VZV) a significantly lower interferon production was found in MS patients compared with the NC patients and the healthy controls; when the NC patients were compared with the healthy controls a significantly lower production was also found. The lymphocyte transformation reaction in seropositive MS patients was significantly lower than that seen in the seropositive control groups when HSV was used as antigen. Lower responses, although insignificant, were found when CMV and VZV were used as antigens. There were no differences among the three groups when Con A was used as mitogen in three different concentrations. Likewise spontaneous lymphocyte transformations were equal. The lower interferon production and the lower transformation reactions in MS patients could not be correlated to age, duration of disease, disability, disease activity or impairment. No significant differences in humoral immunity to HSV, CMV and VZV were found in the three groups, a few MS patients were 'true' seronegative to HSV type 1 and 2. Suppressor cell activity induced by Con A and measles virus was comparable in the three groups, although a few MS patients in an active relapsing phase were found to have low suppressor cell activity. Natural killer cell activity against two different cell lines was found equal in the three groups, and there was no difference in the potentiating effect of interferon.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Haahr, and A Møller-Larsen, and E Pedersen
April 1978, Acta neurologica Scandinavica,
S Haahr, and A Møller-Larsen, and E Pedersen
December 1984, Rinsho shinkeigaku = Clinical neurology,
S Haahr, and A Møller-Larsen, and E Pedersen
November 1971, Nihon rinsho. Japanese journal of clinical medicine,
S Haahr, and A Møller-Larsen, and E Pedersen
November 2006, Rinsho shinkeigaku = Clinical neurology,
S Haahr, and A Møller-Larsen, and E Pedersen
January 1966, Proceedings of the Australian Association of Neurologists,
S Haahr, and A Møller-Larsen, and E Pedersen
December 1980, Nihon rinsho. Japanese journal of clinical medicine,
S Haahr, and A Møller-Larsen, and E Pedersen
February 1983, Acta neurologica Scandinavica,
S Haahr, and A Møller-Larsen, and E Pedersen
December 1973, Lancet (London, England),
S Haahr, and A Møller-Larsen, and E Pedersen
December 1976, Acta pathologica et microbiologica Scandinavica. Section C, Immunology,
Copied contents to your clipboard!